Today: 9 June 2026
Blackstone stock (BX): FERC clears $11.5B TXNM deal as private-credit nerves hang over Monday

Blackstone stock (BX): FERC clears $11.5B TXNM deal as private-credit nerves hang over Monday

New York, Feb 22, 2026, 14:12 EST — The session wrapped up with the market now closed.

  • Blackstone finished Friday at $121.27, losing roughly 3.5%.
  • Blackstone Infrastructure’s $11.5 billion TXNM Energy acquisition picked up approval from a U.S. energy regulator, and the antitrust waiting period in the U.S. has now run out.
  • Private-credit mood and what regulators do next with the TXNM deal are front and center for investors as Monday gets underway.

Blackstone picked up a key regulatory approval Friday: TXNM Energy announced that FERC signed off on its sale to Blackstone Infrastructure, while the Hart-Scott-Rodino antitrust period also ran out. Shares of Blackstone didn’t catch a break, sliding $4.46, or 3.5%, to close at $121.27.

This clearance is important—big infrastructure projects often get stuck at the approval stage, so having a federal green light takes one delay off the table. Shares, though, have stayed in step with sector peers, and lately, investors are weighing a different set of factors for the group.

Pressure is mounting on listed alternative managers as investors question both liquidity and asset valuations in private markets. Private credit sits at the heart of this, driven by rapid growth, but selling these loans—typically issued by non-bank lenders—can be tricky.

Concerns resurfaced this week as Blue Owl’s move to tweak a retail-oriented debt fund sent shockwaves across the industry. “This is about the mismatch between the need for liquidity and what the managers can deliver,” said Steve Wyett, chief investment strategist at BOK Financial. Oppenheimer analyst Chris Kotowski pushed back, adding that “people have been jumping to unwanted conclusions.” Reuters

Albuquerque-based TXNM said the Federal Energy Regulatory Commission brushed aside concerns over Blackstone’s data-center and utility investments, relying on ring-fencing rules in Texas and New Mexico. TXNM noted it has secured the Federal Communications Commission’s blessing, plus a Texas Public Utility Commission settlement in its pocket. Still on the to-do list: approvals from the Nuclear Regulatory Commission and the New Mexico Public Regulation Commission.

Another SEC filing revealed director Ruth Porat picked up approximately 525 Blackstone shares on Feb. 17, paying between $130 and $131 each. That tally includes shares acquired through dividend reinvestment as well as a family partnership. Insider buying often flies under the radar, but stakes like this attract attention, especially if the stock’s struggling.

UBS dropped its price target for Blackstone on Friday, lowering it to $137 from $171 but sticking with a neutral rating, MT Newswires said. Shares of Blackstone have fallen around 6.6% in the last five sessions, MarketScreener data show.

Tone on private credit has grown noticeably sharper in recent days. Mohamed El-Erian, the former Pimco chief, posed the question: “Is this a ‘canary-in-the-coalmine’ moment, similar to August 2007?” Investopedia

Even with a regulatory green light, Blackstone isn’t shielded if private-credit troubles escalate—think higher defaults, fire sales, or investors pulling out quicker than assets can be sold. As for the TXNM deal, additional sign-offs might tack on new requirements or delays, which can take the shine off, positive headlines or not.

Macro takes a back seat for now. The BEA’s schedule lists March 13 for the next personal income and outlays report—the one that features the Fed’s go-to inflation metric, the PCE price index. That update lands the same day as the second reading on Q4 GDP. Eyes then turn to the Fed’s policy meeting, set for March 17-18.

Blackstone expects to wrap up the TXNM acquisition in the back half of 2026, pending sign-offs and standard closing steps. But for Blackstone shares, attention shifts to Monday’s open—traders are watching to see if private-credit jitters subside or ripple through the sector again.

Stock Market Today

  • Docebo (TSX:DCBO) Valuation Story Shifts Amid Revised Earnings Guidance
    June 9, 2026, 10:40 AM EDT. Docebo's fair value remains at CA$35.97 despite updated financial models, reflecting a recalibration of valuation assumptions. Analysts highlight contrasting bullish views, citing a clear growth story backed by recent revenue guidance raising full-year 2026 estimates to US$271-275 million, against bearish concerns over limited analyst coverage and potential risks. The e-learning software provider forecast revenue of approximately US$65.4-65.6 million for Q1 2026, and US$66.7-66.9 million for Q2. At its Inspire 2026 event, Docebo unveiled a next-generation learning platform and key product updates, signaling strategic progress. Investors should monitor shifting assumptions and sector context amid evolving market narratives.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Visa stock set for Monday as Mexico blocks Prosa deal after the bell
Previous Story

Visa stock set for Monday as Mexico blocks Prosa deal after the bell

National Grid share price ticks up as Ofgem flags AI data-centre power crunch
Next Story

National Grid share price ticks up as Ofgem flags AI data-centre power crunch

Go toTop